- Report
- February 2023
- 206 Pages
Global
From €3026EUR$3,185USD£2,595GBP
€4323EUR$4,550USD£3,707GBP
- Report
- May 2023
- 74 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- May 2023
- 90 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- May 2023
- 147 Pages
Global
From €5699EUR$5,999USD£4,887GBP
- Report
- May 2023
- 147 Pages
Global
From €5699EUR$5,999USD£4,887GBP
Allogeneic stem cells are stem cells derived from a donor, typically from a family member, and used to treat a variety of diseases and conditions. Allogeneic stem cells are used in a variety of medical treatments, including bone marrow transplants, cancer treatments, and regenerative medicine. Allogeneic stem cells are also used in research to study the effects of stem cells on diseases and conditions.
The allogeneic stem cell market is a rapidly growing field, with a variety of companies offering products and services related to stem cell research and treatments. Companies in the allogeneic stem cell market include Celgene, Novartis, and Osiris Therapeutics, which offer products and services related to stem cell research and treatments. Other companies in the market include BioTime, Athersys, and Mesoblast, which offer products and services related to stem cell therapies. Show Less Read more